Product Program year 2020 Source: CMS Open Payments

Vysis UroVysion

Device Molecular Diagnostics

Open in the dashboard

General payments

$386

21 payments

Research payments

$2,485

3 payments

Through program year 2020, $386 in general payments and $2,485 in research payments were reported against Vysis UroVysion (Molecular Diagnostics).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2020 Research $500 1
2019 General $386 21
2019 Research $1,985 2

Breakdown

Who paid General payments · program year 2019
  1. Abbott Laboratories $386 21 payments
Top recipients General payments · program year 2019
  1. Amanda Bonvicino Cytopathology · Highlands Ranch, CO $23 6% · 1 payment
  2. Leila Langston Dermatopathology · Denver, CO $23 6% · 1 payment
  3. Norman Henkes Anatomic Pathology & Clinical Pathology · San Antonio, TX $19 5% · 1 payment
  4. Jaime Furman Anatomic Pathology · San Antonio, TX $19 5% · 1 payment
  5. Elizabeth Miller Urology · Bellevue, WA $19 5% · 1 payment

The top 5 of 21 recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Urology $255 66% · 14 practitioners
  2. Anatomic Pathology & Clinical Pathology Pathology $48 12% · 3 practitioners
  3. Dermatopathology Pathology $23 6% · 1 practitioner
  4. Cytopathology Pathology $23 6% · 1 practitioner
  5. Anatomic Pathology Pathology $19 5% · 1 practitioner

The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. Virginia $197 51% · 11 recipients
  2. Washington $75 20% · 4 recipients
  3. Colorado $47 12% · 2 recipients
  4. Texas $39 10% · 2 recipients
  5. New Jersey $17 4% · 1 recipient

The top 5 of 6 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

21 general · 3 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record